
Median Technologies Reports Full-year 2024 Financial Results
SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, 'Median' or the 'Company'), manufacturer of eyonis™, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, today reported its 2024 consolidated annual financial results, as of December 31, 2024. The consolidated financial statements for the financial year ended December 31, 2024, were audited and approved by the Company's Board of Directors on April 28, 2025.
Fredrik Brag, CEO of Median Technologies, commented: 'Median Technologies made significant financial progress in 2024, with growth in revenue and a narrower net loss. Operational efficiencies, announced in 2024, will deliver full results throughout 2025. Our order backlog is at its all-time high. In parallel, we are advancing on the clinical front with the achievement of several significant milestones which pave the way for further important progress through 2025. We successfully completed REALITY, the first pivotal study of our Software as a Medical Device (SaMD) eyonis™ LCS for computer aided detection and diagnosis of lung cancer, in August 2024 and RELIVE, the second and last pivotal study, in March 2025. The U.S. alone has 14.5 million people eligible for an imaging lung cancer screening test and there is already a $650 reimbursement code for the post processing of medical imaging using AI. Our AI-driven SaMD will identify cancer patients at the stage when they could be cured, while also avoiding the significant costs to healthcare systems by reducing the false positives and treatments at a late stage.
'As we move through 2025, we expect to reach further value inflection points including U.S. 510(k) filing of eyonis™ LCS in May, paving the way for commercial launch by the end of the year, and the European CE marking filing in June. Our recent major iCRO agreement with a Top 3 pharma group is already providing strong traction for future growth. After three years of technology investments, iCRO can capitalize on its service differentiation and operational profitability in 2025 to become financially sustainable, enabling Median to focus investments on the eyonis™ LCS commercial launch.'
2024 Financial Highlights
On January 31, 2025, the Company reported key business indicators for 2024, and confirms today the audited figures as follows:
Full year revenue of €22.9 million as of December 31, 2024,
Order backlog 1 at €71.0 million as of December 31, 2024, compared to €66.9 million as of December 31, 2023, a 6.1% YoY increase,
Cash and cash equivalents of €8.1 million as of December 31, 2024.
Consolidated statement of cash flows under IFRS accounting rules
Net cash flow consumption from operating activities decreased from €20.2 million in 2023 to €17.9 million in 2024, driven primarily by working capital efficiencies.
Cash and cash equivalents at end of period totaled €8.1 million, compared to €19.5 million at end-2023. The Company's cash position was bolstered in early January 2024 with the drawdown of €8.5m of the second tranche of the 2020 financing facility granted by the European Investment Bank (EIB).
Net income statement under IFRS accounting rules
Median's 2024 revenue stemmed entirely from the iCRO Business Unit, which provides imaging services to measure drug efficacy in industry-sponsored oncology trials. 2024 full-year revenue was €22.9 million, a 3.3% increase compared to €22.2 million in 2023. Revenue growth accelerated in the second half of 2024 and were 10.2% higher compared to revenues over the same period the prior year.
2024 staff costs were down €1.7 million compared to 2023, from €25.5 million in 2023 to €23.8 million in 2024, primarily due to a decrease in employees' share-based payments. Full year payroll costs remained stable in 2024, which do not yet reflect the significant improvements to enhance the profitability of iCRO operations in H2, 2024. Total headcount decreased from 259 on Dec. 31, 2023, to 227 on Dec. 31, 2024.
2024 external expenses were up €0.6 million compared to 2023.
In total, operating loss narrowed slightly, from €23.1 million in 2023 to €22.5 million in 2024.
Net financial income was negative in 2024, mainly due to an increase in interest and financial charges of €1.9 million relating to the EIB tranche B financing and the Celestial Successor Fund (CSF) bonds. Most of these interest charges are capitalized, €0.4 million are paid in cash.
In total, net loss increased by €2.3 million in 2024, compared to 2023.
2024 operational highlights
2024 operational highlights were published on January 31, 2025.
Events subsequent to the financial year-end period
Q1 2025 significant events were published .
Notable highlights include:
The Company's cash position was strengthened in January 2025 with the receipt of €4 million from the initial tranche of the €10 million equity line completed with IRIS, as announced in January 2025. It was further reinforced later in the first quarter with the advanced payment of the 2024 French research and innovation tax credit, of €1.4 million.
In Q1 2025, Median and the European Investment Bank (EIB) extended the maturity of the financing facility granted in 2020 by six months, i.e., until October 2025. Furthermore, as previously announced and communicated on the EIB website, the Company is working with the EIB on finalizing an agreement for a new financing facility of up to €37.5 million in the coming weeks, to enable the regulatory and commercialization activities of eyonis™ LCS. Upon completion of the agreement, which would trigger the drawdown of a first tranche, the Company estimates that it will be able to cover its financing needs until Q4 2025.
Subsequent tranches of the EIB financing facility will be made available upon completion of certain undisclosed milestones. Fulfilment of these milestones, enabling further drawdowns, should contribute to extending the Company's cash runway until at least the end of 2026.
Company upcoming milestones by year-end
eyonis™ Lung Cancer Screening (LCS) U.S. FDA 510(k) filing on track for May 2025.
eyonis™ LCS filing for CE marking expected in June 2025.
eyonis™ LCS commercial launch as soon as year-end 2025 in U.S. pending FDA 510(k) clearance.
eyonis™ LCS commercial launch expected in H1 2026 in Europe, pending CE marking.
iCRO will continue to increase its profitability, the increase of the order backlog will drive future growth.
Median Technologies informs its shareholders and the financial community that its annual financial report on the accounts for the year ended December 31, 2024, has been made available and filed with the French financial market authority (Autorité des Marchés Financiers).
The annual financial report is available on the Company's website: https://mediantechnologies.com/investors/financial-results-and-reports/
About Median Technologies: Pioneering innovative imaging solutions and Software as a Medical Device, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median's offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis™, an AI/ML tech-based suite of software as a medical device (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit www.mediantechnologies.com.
Forward-Looking Statements
This press release contains forward-looking statements. These statements are not historical facts. They include projections and estimates as well as the assumptions on which these are based, statements concerning projects, objectives, intentions, and expectations with respect to future financial results, events, operations, services, product development and potential, or future performance.
These forward-looking statements can often be identified by the words "expects," "anticipates," "believes," "intends," "estimates" or "plans" and any other similar expressions. Although Median's management believes that these forward-looking statements are reasonable, investors are cautioned that forward-looking statements are subject to numerous risks and uncertainties, many of which are difficult to predict and generally beyond the control of Median Technologies, that could cause actual results and events to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements.
All forward-looking statements in this press release are based on information available to Median Technologies as of the date of the press release. Median Technologies does not undertake to update any forward-looking information or statements, subject to applicable regulations, in particular Articles 223-1 et seq. of the General Regulation of the French Autorité des Marchés Financiers.
1 The order backlog is the sum of orders received but not yet fulfilled. An increase or decrease in the order backlog corresponds to the order intake of the reporting period, net of invoiced services, completed or cancelled contracts, and currency impact for projects in foreign currency (re-evaluated at the exchange rate on closing date). Orders are booked once the customer confirms, in writing, its retention of the Company's services for a given project. The contract is usually signed a few months after written confirmation.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
KI Celebrates Best of NeoCon 2025 Recognition for the Cogni Classroom Chair
Reinforcing KI's Commitment to Innovation in Flexible and Active Learning Spaces. GREEN BAY, Wis., June 09, 2025--(BUSINESS WIRE)--KI is proud to announce its success at this year's Best of NeoCon awards competition, with one of its newest innovations receiving Silver honors at North America's most prestigious commercial interiors awards program. This recognition reinforces KI's commitment to thoughtful, flexible and forward-thinking design solutions for today's evolving learning, working and healing environments. "We are incredibly honored to be recognized by the Best of NeoCon judges for the Cogni Classroom Chair," said Tony Besasie, chief marketing and sales officer at KI. "The Best of NeoCon Silver Award validates the passion and purpose our design and engineering teams bring to each product we develop. Every piece reflects KI's belief in creating intelligent, adaptable solutions that meet the real needs of our customers across industries." Cogni™ classroom seating redefines the student experience with intuitive support, durable construction and the flexibility required in today's active learning spaces. Designed with ergonomic comfort and motion in mind, Cogni encourages natural movement to promote student engagement and focus. "With Cogni, we set out to rethink what classroom seating could be," said Besasie. "We know that movement is essential to focus and learning. Cogni encourages that movement—offering intuitive comfort that adapts to the learner, not the other way around. It's a thoughtful response to how students truly engage in today's classrooms." This recognition comes as KI marks its final NeoCon showcase at The Mart before moving to its new showroom in Fulton Market in 2026. "As we reflect on our legacy at The Mart and look ahead to our future at Fulton Market, it is especially meaningful to be honored this year," said Besasie. "This moment encapsulates KI's evolution, rooted in design excellence and always looking forward." ABOUT KI KI manufactures innovative furniture for education, healthcare, government and corporate markets. The employee-owned company is headquartered in Green Bay, Wisconsin, with sales and manufacturing facilities worldwide. KI tailors products and service solutions to the specific needs of each customer through its unique design and manufacturing philosophy. For more information, visit View source version on Contacts Media Contact: Shelly SchumacherVice President, Public RelationsNelson Schmidt Inc.262-305-1713sschumacher@
Yahoo
27 minutes ago
- Yahoo
Fortune Media and Great Place To Work Name Agiloft to 2025 Fortune Best Workplaces in the Bay Area
The leader in CLM invests in employee experiences, from remote flexibility to professional development, driving both workplace satisfaction and exceptional customer outcomes REDWOOD CITY, Calif., June 9, 2025 /PRNewswire/ -- Agiloft, the global value leader in data-first contract lifecycle management (CLM), announced today Great Place To Work® and Fortune magazine have honored Agiloft as one of this year's Best Workplaces in the Bay Area. This is the first time the company has been named to this prestigious list. Earning a spot means that Agiloft has surpassed rigorous benchmarks, establishing itself as one of the best workplaces in the San Francisco Bay region. To determine the Fortune Best Workplaces in the Bay Area™ List, Great Place To Work collected nearly 85,000 confidential survey responses from employees at eligible companies via its proprietary platform. Companies were ranked based on their ability to offer consistently positive experiences, building trust with leaders, colleagues, and the overall organization. "Our philosophy has always been simple: when employees are supported, engaged, and empowered, they can deliver extraordinary experiences for our customers," said May Quock, VP of People Operations at Agiloft. "We are so grateful for our dedicated employees who have made us a part of this list. It is a reflection of our team's dedication and the meaningful culture we continue to build together." The Best Workplaces in the Bay Area list is highly competitive. Survey responses reflect a comprehensive picture of the workplace experience. Honorees were rewarded based on their ability to deliver positive outcomes for employees regardless of role or status within the organization. To be eligible for the list, companies must be Great Place To Work Certified™, have at least 10 U.S. employees, and be headquartered in the San Francisco Bay Area. "Congratulations to the Fortune Best Workplaces in the Bay Area," says Michael C. Bush, CEO at Great Place To Work. "These companies prove that prioritizing people leads to better performance, and that leaders who invest in their people are rewarded with more sustainable and profitable businesses." Earlier this year, Agiloft became Certified™ by Great Place To Work.® The certification is based entirely on what current employees say about their experience working at Agiloft, resulting in 88 percent of employees saying that Agiloft is a great place to work – 31 points higher than the average U.S. company. Agiloft believes great employee experiences drive superior customer experiences (EX=CX). The company offers a remote-first workplace, quarterly wellness days, Summer Fridays, and supports several employee resource groups. It also provides a strong personal and professional development program to help employees thrive. To view the entire Fortune Best Workplaces in the Bay Area™ 2025 List, visit here. Looking to grow your career at a company that puts its people first? Visit our careers page at About AgiloftAgiloft is the global value leader in data-first contract lifecycle management (CLM), offering the industry's only no-code platform with AI on the Inside™ to enhance efficiency, cut review times by up to 80%, and accelerate business. Its Data-first Agreement Platform (DAP) transforms contracts into strategic, data-rich assets, integrating with 1,000+ systems to drive decisions and efficiency. Trusted by brands like Alkermes, Balluff, and TaylorMade, Agiloft boasts a 96% renewal rate and 100% satisfaction for implementations. Backed by KKR, JMI Equity, and FTV Capital, Agiloft empowers businesses to drive smarter strategies, faster decision-making and game-changing competitive advantage. Learn more at About the Fortune Best Workplaces in the Bay AreaGreat Place To Work selected the Fortune Best Workplaces in the Bay Area List by surveying 1.3 million employees in the U.S., representing companies that collectively employ more than 8.4 million U.S. workers. Of those responses, nearly 85,000 were received from employees at companies that were eligible for the 2025 Fortune Best Workplaces in the Bay Area List and these rankings are based on their feedback. Companies earn eligibility by being Great Place To Work Certified™, having at least 10 U.S. employees, and having headquarters in the Bay Area. Read the full methodology. To get on this list next year, start here. About Great Place To WorkAs the global authority on workplace culture, Great Place To Work brings more than three decades of groundbreaking research and data to help every place become a great place to work for all. Its proprietary platform and Great Place To Work Model™ help companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified and receiving recognition on its coveted Best Workplaces™ lists. Follow Great Place To Work on LinkedIn, Twitter, and Instagram or visit and sign up for the newsletter to learn more. About FortuneFortune upholds a legacy of award-winning writing and trusted reporting for executives who want to make business better. Independently owned, with a global perspective and digital agility, Fortune tells the stories of a new generation of innovators, builders, and risk-takers. Online and in print, Fortune measures corporate performance through rigorous benchmarks and holds companies accountable. Fortune creates communities by convening true thought leaders and iconoclasts — those who shape industry, commerce, and society — through powerful and prestigious lists, events, and conferences, such as the iconic Fortune 500, the CEO Initiative and Most Powerful Women. For more information, visit Media ContactAngel DuanSenior Manager, Corporate Communications396010@ (650) 780-6741 ext. 5775 View original content: SOURCE Agiloft


Business Wire
41 minutes ago
- Business Wire
KI Celebrates Best of NeoCon 2025 Recognition for the Cogni Classroom Chair
GREEN BAY, Wis.--(BUSINESS WIRE)--KI is proud to announce its success at this year's Best of NeoCon awards competition, with one of its newest innovations receiving Silver honors at North America's most prestigious commercial interiors awards program. This recognition reinforces KI's commitment to thoughtful, flexible and forward-thinking design solutions for today's evolving learning, working and healing environments. "We are incredibly honored to be recognized by the Best of NeoCon judges for the Cogni Classroom Chair,' said Tony Besasie, chief marketing and sales officer at KI. Share 'We are incredibly honored to be recognized by the Best of NeoCon judges for the Cogni Classroom Chair,' said Tony Besasie, chief marketing and sales officer at KI. 'The Best of NeoCon Silver Award validates the passion and purpose our design and engineering teams bring to each product we develop. Every piece reflects KI's belief in creating intelligent, adaptable solutions that meet the real needs of our customers across industries.' Cogni™ classroom seating redefines the student experience with intuitive support, durable construction and the flexibility required in today's active learning spaces. Designed with ergonomic comfort and motion in mind, Cogni encourages natural movement to promote student engagement and focus. 'With Cogni, we set out to rethink what classroom seating could be,' said Besasie. 'We know that movement is essential to focus and learning. Cogni encourages that movement—offering intuitive comfort that adapts to the learner, not the other way around. It's a thoughtful response to how students truly engage in today's classrooms.' This recognition comes as KI marks its final NeoCon showcase at The Mart before moving to its new showroom in Fulton Market in 2026. 'As we reflect on our legacy at The Mart and look ahead to our future at Fulton Market, it is especially meaningful to be honored this year,' said Besasie. 'This moment encapsulates KI's evolution, rooted in design excellence and always looking forward.' ABOUT KI KI manufactures innovative furniture for education, healthcare, government and corporate markets. The employee-owned company is headquartered in Green Bay, Wisconsin, with sales and manufacturing facilities worldwide. KI tailors products and service solutions to the specific needs of each customer through its unique design and manufacturing philosophy. For more information, visit